⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Official Title: A Study of the Efficacy and PK/PD Relationship of Monotherapy MORAb-004 in Subjects With Metastatic Melanoma

Study ID: NCT01335009

Study Description

Brief Summary: This is a global, Phase 2, open label, dose selection, proof-of-concept study to assess progression free survival in subjects with metastatic melanoma. Approximately 80 subjects at 29 sites in the U.S., U.K., Germany and Australia will be randomized into one of two dose groups: 2 mg/kg, 4 mg/kg. Weekly treatment will continue until disease progression. Subjects must have measurable disease by CT Scan or MRI and must have completed at least one prior round of chemotherapy. Subjects will be assessed for Efficacy, PK/PD, Overall survival, and Safety (Adverse Events/Adverse Events of Interest, Electrocardiograms (ECG's), clinical labs, physical exams/vital signs, tolerability).

Detailed Description: MORAb-004 is a monoclonal antibody directed against endosialin, a cell surface glycoprotein, which is expressed on cells involved in tumor vasculature. Studies have found endosialin to play a key role in tumor growth and neovessel formation in numerous cancer types including melanoma. Preclinical pharmacological studies have shown that MORAb-004 is a potentially useful anti-cancer agent. This clinical trial is being performed to determine the efficacy of MORAb-004 at two dose levels in subjects with metastatic melanoma, as well as to establish serum pharmacokinetics and pharmacodynamics of the antibody.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Pinnacle Oncology, Scottsdale, Arizona, United States

The Angeles Clinic and Research Institute, Los Angeles, California, United States

University of California Los Angeles, Los Angeles, California, United States

University of Colorado Cancer Center, Anschutz Cancer Pavilion, Aurora, Colorado, United States

Yale University, New Haven, Connecticut, United States

The University Of Chicago, Chicago, Illinois, United States

Oncology Specialists, SC, Park Ridge, Illinois, United States

University of Iowa Hospital, Iowa City, Iowa, United States

University of Minnesota, Minneapolis, Minnesota, United States

Washington University School of Medicine, Saint Louis, Missouri, United States

Atlantic Health, Morristown, New Jersey, United States

New York University Cancer Institute, New York, New York, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Duke University Medical Center, Durham, North Carolina, United States

St. Luke's Hospital & Health Network, Bethlehem, Pennsylvania, United States

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States

Sydney Cancer Center - Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Newcastle Melanoma Unit, Calvery Mater Newcastle, Waratah, New South Wales, Australia

The Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia

Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Universitatsklinikum Essen, Klinik fur Dermatologie, Essen, , Germany

Universitats-Hautklinik, Mainz, , Germany

Eberhard Karls University Tuebingen, Tuebingen, , Germany

The Royal Marsden Hospital, London, , United Kingdom

Weston Park Hospital, Sheffield, , United Kingdom

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: